AI & Analytics Enhance Clinical Trial Design Efficiency
Artificial intelligence (AI) and advanced analytics are poised to revolutionize the field of clinical trial protocol design. These cutting-edge technologies, when combined with real-world data, have the potential to significantly improve the efficiency, cost-effectiveness, and success rates of clinical trials. This transformative potential holds great promise for both patients and researchers.
In an upcoming webinar scheduled for Thursday, September 28th, 2023, experts in data science will delve into the ways in which real-world data can be effectively utilized to enhance clinical trial design. The webinar will specifically explore how AI and analytics can facilitate data-driven decision making throughout the trial design process.
Lucas Glass, Vice President of the IQVIA Analytics Center of Excellence (ACOE), will be one of the featured speakers. With over 15 years of experience in pharmaceutical data science, Glass leads a team of more than 200 data scientists, engineers, and product managers dedicated to researching, developing, and operationalizing machine learning and data science solutions within the realm of research and development (R&D).
Glass has played a pivotal role in launching numerous machine learning offerings within R&D, including site recommender systems, trial matching solutions, enrollment rate algorithms, drug target interactions, drug repurposing, and molecular optimization. His work has earned recognition and acceptance at esteemed AI conferences such as AAAI, WWW, NIPS, ICML, JAMIA, KDD, and others.
Joining Glass as a speaker is Pablo Aran Terol, Senior Product Manager at the IQVIA Analytics Center of Excellence. Terol holds a PhD in Biophysics from the University of Cambridge and has a decade of experience in the life sciences field. His background includes extensive research on the biophysical processes underlying Alzheimer’s Disease.
Terol’s career in clinical research began as a consultant at IQVIA, where he contributed to clinical development programs, pricing strategies, market access initiatives, and asset evaluation. Over time, he transitioned to offering development, strategic planning, and eventually assumed his current role as Senior Product Manager.
Within the IQVIA Analytics Center of Excellence, Terol leads the strategy and development of cutting-edge technology designed to analyze clinical trial protocol designs, mitigating risks and expediting the delivery of therapies to patients.
The webinar will provide valuable insights into the potential benefits of integrating real-world data and AI in clinical trial protocol design. By facilitating data-driven decision making, these advancements offer the promise of enhanced trial efficiency, cost-effectiveness, and ultimately, improved patient outcomes. Furthermore, health systems and researchers stand to benefit from the increased likelihood of successful trial outcomes.
To learn more about the exciting future of AI and analytics in the realm of clinical trial design, register for the webinar on Thursday, September 28th, 2023, at 10am EDT | 7am PDT | 3pm BST | 4pm CEST. Gain a deeper understanding of how real-world data can be harnessed to optimize trial protocols, resulting in more efficient and successful clinical trials that bring therapies to patients faster.
The future of clinical trial design is here, and it is powered by AI and advanced analytics. Embrace the potential of this transformative technology and join the webinar to stay at the forefront of this groundbreaking field.
